Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid

Journal of Periodontal Research

Volumn 33, Issue 7, 1998, Pages 434-437

  Kido, Jun Ichi ^a   Nakamura, Teruo ^a   Kido, Reiko ^a   Ohishi, Keiji ^a   Yamauchi, Noriyuki ^a   Kataoka, Masatoshi ^a   Nagata, Toshihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Calprotectin; Gingival crevicular fluid; Periodontal disease

Indexed keywords

CALGRANULIN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTITIS;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PERIODONTITIS; STATISTICS, NONPARAMETRIC;

EID: 0032176433     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02340.x     Document Type: Article

References (24)

1. Socransky SS. Relationship of bacteria to the etiology of periodontal disease. J Dent Res 1970; 49: 203-222.
2. Genco RJ, Slots J. Host responses in periodontal diseases. J Dent Res 1984; 63: 441-451.
3. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 1984; 11: 21-32.
4. Embery G, Waddington R. Gingival crevicular fluid: biomarkers of periodontal tissue activity. Adv Dent Res 1994; 8: 329-336.
5. Nakashima K, Giannopoulou C, Andersen E, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996; 23: 832-838.
6. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1α and -1β in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990; 25: 156-163.
7. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986; 21: 101-112.
8. Palcanis KG, Larjava IK, Wells BR, et al. Elastase as an indicator of periodontal disease prognosis. J Periodontol 1992; 63: 237-242.
9. Lamster IB, Oshrain RL, Harper DS, Celenti RS, Hovliaras CA, Gordon JM. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis. J Periodontol 1988; 59: 516-523.
10. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol 1980; 24: 393-398.
11. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134: 1-6.
12. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelo-monucytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987; 87: 700-707.
13. Andersson KB, Sletten K, Berntzen HB, et al. The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28: 241-245.
14. Fagerhol MK, Andersson KB, Naess-Andrcsen C-F, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, eds. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton Ann Arbor Boston: CRC Press, 1990: 187-210.
15. Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357-362.
16. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1996: 74: 136-139.
17. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793-798.
18. Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 1416-1420.
19. Kido J, Nishikawa S, Ishida H, et al. Identification of calprotectin, a calcium binding leukocyte protein, in human dental calculus matrix. J Periodont Res 1997: 32: 355-361.
20. 2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 1996; 67: 755-762.
21. Cuida M, Brun JG, Tynning T, Jonsson R. Calprotectin levels in oral fluids: the importance of collection site. Eur J Oral Sci 1995; 103: 8-10.
22. Miyasaki KT, Bodeau AL, Murthy ARK, Lehrer RI. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena J Dent Res 1993; 72: 517-523.
23. Brun JG, Cuida M, Jacobsen H, et al. Sjogren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva. Scand J Rheumatol 1994; 23: 114-118.
24. Eversole LR, Miyasaki KT, Christensen RE. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med 1993; 22: 303-307.